Device Transactions Device financing during 2015's third quarter reached $1.4 billion, a 22% dip from Q2's $1.8 billion total. ( See Exhibit 1. ) Late-stage venture capital rounds represented most of
IN VITRO DIAGNOSTICS 23andMe Inc. 23andMe completes $150mm Series E financing 23andMe Inc. , which sells DNA testing kits directly to consumers who contribute their data to large-scale genetic